Volume 11, Number 4—April 2005
Human Spotted Fever Rickettsial Infections
||EIA and/or IFA
|No. tested†||No. positive (%)‡||No. tested†||No. positive (%)§||No. tested†||No. positive (%)|
|Cusco||36||6 (17)||56||11 (20)||67||16 (24)|
|Junin||42||8 (19)||19||2 (11)||53||10 (19)|
|Piura||50||4 (8)||0||50||4 (8)|
|Total||128||18 (14)||75||13 (17)||170||30 (18)|
*By enzyme immunoassay (EIA) or indirect immunofluorescence antibody assay (IFA).
†Febrile patients from whom acute- and convalescent-phase serum specimens were available for testing.
‡Criterion for confirmation was a ≥4-fold increase in R. rickettsii immunoglobulin (Ig) G antibody titer from acute to convalescent phase of illness by EIA.
§Criterion for confirmation was a ≥4-fold increase in R. rickettsii IgG antibody titer from acute to convalescent phase of illness by IFA.
- Page created: May 23, 2011
- Page last updated: May 23, 2011
- Page last reviewed: May 23, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)